NASDAQ
AC Immune S.A. (ACIU) reported revenue of $3.57M and net income of $-70,447,000 for FY 2025, with a net profit margin of -1971.6%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.